Publications

Peer-Reviewed Manuscripts

• Distinct inactivated bacterial-based immune modulators vary in their therapeutic efficacies for treating disease based on the organ site of pathology.
• Novel Microbial-Based Immunotherapy Approach for Crohn’s Disease.
• Immune Stimulation Using a Gut Microbe-Based Immunotherapy Reduces Disease Pathology and Improves Barrier Function in Ulcerative Colitis. 
• Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapy.
• Attenuating immune pathology using a microbial-based intervention in a mouse model of cigarette smoke-induced lung inflammation.
• A novel microbe-based treatment that attenuates the inflammatory profile in a mouse model of allergic airway disease.
• Site-Specific Immunomodulator: A Novel Treatment for Crohn’s Disease.